Akso Health (AHG) Operating Leases (2018 - 2025)
Akso Health (AHG) reported Operating Leases of -$18684.0 for Q3 2025, up 14.38% on a YoY basis from -$16335.0 in Q3 2024, and down 144.83% quarter-over-quarter from $41679.0 in Q1 2025.
Akso Health (AHG) Operating Leases (2018 - 2025) Analysis & Trends
Akso Health has reported Operating Leases for 5 years, with the latest figure at -$18684.0 in Q3 2025.
- For the quarter ending Q3 2025, Operating Leases rose 14.38% year-over-year to -$18684.0; the trailing twelve-month figure through Sep 2025 stood at -$18684.0 (up 14.38% YoY), and the FY2025 full-year result was $41679.0, changed N/A from the prior year.
- Operating Leases for Q3 2025 stood at -$18684.0, down from $41679.0 in the prior quarter.
- The five-year high for Operating Leases was $41679.0 in Q1 2025, with the low at -$21822.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -18,684.00 |
| Mar 31, 2025 | 41,679.00 |
| Sep 30, 2024 | -21,822.00 |
| Mar 31, 2020 | 13,498.00 |
| Sep 30, 2019 | 753,998.00 |
| Mar 31, 2018 | 2.56 Mn |